asparaginase

Documents about asparaginase

• Outcome Following Truncation of Asparaginase#966667ClinicalTrials.gov
• Raw X-ray diffraction data for wild-type Escherichia coli type III L-asparaginase#433657MX-RDR Dataverse OAI Archive
• Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer#852243ClinicalTrials.gov
• Raw X-ray diffraction data for the N67S mutant of Escherichia coli type III L-asparaginase#392247MX-RDR Dataverse OAI Archive
• Raw X-ray diffraction data for the I70H mutant of Escherichia coli type III L-asparaginase#395736MX-RDR Dataverse OAI Archive
• Raw X-ray diffraction data for the I70T mutant of Escherichia coli type III L-asparaginase#395737MX-RDR Dataverse OAI Archive
• Raw X-ray diffraction data for the I70K mutant of Escherichia coli type III L-asparaginase#395738MX-RDR Dataverse OAI Archive
• Raw X-ray diffraction data for the N67D mutant of Escherichia coli type III L-asparaginase#425027MX-RDR Dataverse OAI Archive
• Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase#833508ClinicalTrials.gov
• Real World Asparaginase Therapy Toxicity#812048ClinicalTrials.gov
• Produção de L-asparaginase II recombinante de Erwinia carotovora em cultivos de Escherichia coli em batelada alimentada#946093Repositório PUCRS
• Expressão Heteróloga de asparaginase de Fusarium e Penicillium. Vetor de Expressão constitutiva de baixa expressão pSFOXB1.#187887Repositório Institucional da UnB
• ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase#866273ClinicalTrials.gov
• Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses#850807ClinicalTrials.gov
• A lipid-immune network signature defines susceptibility to asparaginase-associated pancreatitis.#322993NCBI PubMed Central
• The Asparaginase Database: a comprehensive resource and classification of l-asparaginases.#421018NCBI PubMed Central
• 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)#895132ClinicalTrials.gov
• A Study in Adults With Untreated Acute Lymphoblastic Leukemia#831513ClinicalTrials.gov
• Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)#813398ClinicalTrials.gov
• Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas#280444HAL (France)
• Raw X-ray diffraction data: Crystal structure of Rhizobium etli L-asparaginase ReAV C135A mutant (8RUA)#454710MX-RDR Dataverse OAI Archive
• Erwinase Study in Patients With Acute Lymphoblastic Leukemia#850299ClinicalTrials.gov
• High-yield production and functional analysis of novel rhizobial-type glutaminase-free L-asparaginase from Paenibacillus thiaminolyticus.#659836NCBI PubMed Central
• Raw Diffraction data for the crystal structure of Rhizobium etli L-asparaginase ReAV K138A mutant in complex with L-Asn/L-Asp (9SDK)#452388MX-RDR Dataverse OAI Archive
• Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)#307434ClinicalTrials.gov
• VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)#804878ClinicalTrials.gov
• Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia#890810ClinicalTrials.gov
• Treatment of Acute Lymphoblastic Leukemia in Children#842788ClinicalTrials.gov
• Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia#852290ClinicalTrials.gov
• Data Management and Sharing Plan for: SBIR: Development of MM010, a PEG-specific intervention that blocks allergic response and restores repeated dosing for peg-asparaginase in patients with acute lymphoblastic leukemia#207835UNC Dataverse Dataverse OAI Archive
• Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC#843734ClinicalTrials.gov
• Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia#856326ClinicalTrials.gov
• Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment#969617ClinicalTrials.gov
• Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma#898275ClinicalTrials.gov
• A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase#839241ClinicalTrials.gov
• Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy#854631ClinicalTrials.gov